M&A Corner
Getinge to Acquire High Purity New England, Inc., A Leading Provider of Single-Use Solutions for bioprocessing Applications.06 Jun 2023
Getinge, a global medical technology company, has announced its acquisition of High Purity New England (HPNE), a leading US-based company... Continue Reading
|
Seagen Stockholders Approve Acquisition by Pfizer.06 Jun 2023
Seagen shareholders have approved Pfizer’s acquisition proposal, under which Pfizer will acquire Seagen for $229 per share in cash. The... Continue Reading
|
Navigating the Challenges of Biosample Consent in Clinical Trials06 Jun 2023
Biosample collection is crucial for medical research, but it requires clear consent and robust tracking to address compliance and privacy... Continue Reading
|
HeartBeam Forms Strategic Alliance with Samsung06 Jun 2023
HeartBeam, a cardiac technology company, has formed a Strategic Alliance Agreement with Samsung to explore collaboration opportunities in utilizing HeartBeam’s... Continue Reading
|
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals06 Jun 2023
Adamis Pharmaceuticals has completed its merger with DMK Pharmaceuticals. The merged company will focus on increasing sales of Adamis’ commercial... Continue Reading
|
Azelis Acquires Sirius International06 Jun 2023
Azelis, a specialty chemicals and food ingredients provider, will acquire Sirius International to expand its portfolio in home care and... Continue Reading
|
US Hospital EMR Market Share Growth Driven by Small Hospitals06 Jun 2023
A recent report by KLAS highlights trends in the US EMR market in 2022. Oracle Health (Cerner) saw significant growth... Continue Reading
|
Apollo Impact Fund to Acquire UK Construction Firm United Living06 Jun 2023
Apollo Global’s fund, Apollo Impact, will acquire United Living Group, a U.K. provider of infrastructure and construction services. The terms... Continue Reading
|
Strive Health Scores $166M to Scale Value-Based Kidney Care06 Jun 2023
Denver-based kidney care company Strive Health has raised $166 million in a Series C funding round led by NEA and... Continue Reading
|
Eikon Acquires Broad Development Pipeline, Raises $106M in Series C Funding06 Jun 2023
Eikon Therapeutics, led by biopharma expert Roger Perlmutter, has raised $106 million in a Series C financing round and acquired... Continue Reading
|